StockComparison Logo
vs

SON vs AMRX

Comparison between Sonoco Products Company (SON, Company) and Amneal Pharmaceuticals Inc - Class A (AMRX, Company).

SON is from the Consumer Cyclical sector, while AMRX is from the Healthcare sector.

5-Year PerformanceAMRX has outperformed SON, delivering a return of +22.1% compared to -2.0%

SON vs AMRX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
SON
$4.84B
AMRX
$4.84B
Max Drawdown
Winner
SON
62.24%
AMRX
97.52%
Sharpe Ratio
SON
0.48
Winner
AMRX
2.31
5Y Beta
Winner
SON
0.61
AMRX
0.94
Industry
SON
Packaging & Containers
AMRX
Drug Manufacturers - Specialty & Generic
P/E Ratio
Winner
SON
4.76
AMRX
48.60
Forward P/E
SON
8.94
Winner
AMRX
6.30
PEG Ratio
SON
0.01
AMRX
N/A
Dividend Yield
SON
4.45%
AMRX
N/A
5Y Dividends CAGR
SON
8.61%
AMRX
N/A
5Y EPS CAGR
SON
31.39%
AMRX
N/A
Debt to Equity
SON
131.41%
Winner
AMRX
-5663.29%
Free Cash Flow Yield
SON
4.47%
Winner
AMRX
4.97%
P/S Ratio
Winner
SON
0.66
AMRX
1.60
P/B Ratio
Winner
SON
1.38
AMRX
105.45

SON vs AMRX - Historical Returns

Returns include dividend reinvestment.

1M
SON
+0.44%
Winner
AMRX
+28.57%
3M
SON
-3.11%
Winner
AMRX
+33.72%
6M
SON
+21.49%
Winner
AMRX
+32.68%
1Y
SON
+15.84%
Winner
AMRX
+103.52%
5Y(CAGR)
SON
-1.96%
Winner
AMRX
+22.13%
10Y(CAGR)
Winner
SON
+4.22%
AMRX
-6.71%
Max(CAGR)
SON
+6.47%
Winner
AMRX
+7.30%

SON vs AMRX - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearSONAMRX
2026+16.26%+27.96%
2025-4.68%+62.37%
2024-10.91%+32.44%
2023-4.04%+187.68%
2022+9.07%-58.97%
2021+1.99%-1.84%
2020+0.61%-4.19%
2019+21.51%-65.82%
2018+1.65%-23.13%
2017+2.69%+22.88%
2016+34.99%-68.65%
2015-3.00%+34.47%
2014+8.26%+27.64%
2013+42.21%+21.68%
2012-6.86%+0.10%
2011-1.39%-4.32%
2010+16.04%+42.73%
2009+27.11%+186.53%
2008-26.85%N/A
2007-12.64%N/A
2006+33.93%N/A
2005+3.89%N/A
2004+24.79%N/A
2003+9.93%N/A
2002-9.98%N/A
2001+28.88%N/A
2000+2.83%N/A
1999-4.25%N/A

SON vs AMRX Drawdown Comparison

The maximum drawdown for SON was -59.58%, occurring on Mar 9, 2009. Recovery took 1535 trading sessions.

The maximum drawdown for AMRX was -97.52%, occurring on Mar 28, 2023. This drawdown has not yet recovered.

The current SON drawdown is -11.68%. The current AMRX drawdown is -68.43%.

RankSONAMRX
#1-59.58%
Jun 4, 2007 - Jul 9, 2013
-97.52%
Apr 15, 2015 - Mar 28, 2023
#2-41.55%
Jul 5, 2019 - Mar 8, 2021
-48.49%
May 10, 2011 - Jun 6, 2014
#3-33.64%
May 17, 2021 - Oct 30, 2025
-36.82%
Feb 20, 2009 - Jul 23, 2009
#4-32.23%
Apr 10, 2002 - Nov 4, 2004
-27.71%
Jun 15, 2010 - Oct 13, 2010
#5-30.66%
Nov 16, 1999 - Jan 29, 2001
-25.93%
Jul 1, 2014 - Nov 20, 2014
#6-21.71%
Sep 4, 2001 - Dec 21, 2001
-18.07%
Oct 13, 2010 - Jan 14, 2011
#7-19.76%
Feb 26, 2015 - Mar 9, 2016
-17.89%
Jan 15, 2009 - Jan 27, 2009
#8-19.39%
Jan 30, 2001 - May 16, 2001
-16.50%
Feb 15, 2011 - Mar 15, 2011
#9-15.29%
Dec 4, 2017 - Jul 19, 2018
-15.12%
Jan 27, 2009 - Feb 6, 2009
#10-14.45%
Jul 1, 2014 - Dec 11, 2014
-12.18%
May 4, 2010 - May 11, 2010
#11-13.70%
Mar 4, 2005 - Dec 2, 2005
-11.18%
Dec 9, 2014 - Jan 8, 2015
#12-13.25%
Apr 6, 2006 - Sep 12, 2006
-10.44%
Sep 17, 2009 - Oct 5, 2009
#13-13.20%
Dec 3, 2018 - Feb 5, 2019
-9.48%
Oct 6, 2009 - Nov 10, 2009
#14-13.00%
Dec 30, 2004 - Mar 1, 2005
-9.15%
Jan 14, 2010 - Feb 22, 2010
#15-12.72%
Nov 29, 2016 - Dec 1, 2017
-8.34%
Jun 3, 2010 - Jun 15, 2010

Correlation

Correlation between SON and AMRX is -0.52 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.52
-101

Select Stocks to Compare